Mitchell H. Finer, PhD

Chief Scientific Officer,
President of ElevateBio BaseCamp

About Mitch

Mitch founded and is the former CEO of Oncorus, focused on the development of oncolytic herpes viruses for the treatment of solid tumors. He is also a founder and the former CEO of CODA Biotherapeutics, focused on developing a chemogenetic neuromodulation platform for the treatment of severe neurological disorders. Mitch serves on several MPM portfolio company boards, including CODA, Oncorus, Semma Therapeutics and TCR2 Therapeutics.

Prior to joining MPM, he was the CSO of bluebird bio. He has also served as CEO of Intracel Corporation and Genteric, Vice President Research for Cell Genesys and the Gencell division of Aventis Pharma (now Sanofi) and Senior Vice President of Development at Novacell (now Viacyte). He also successfully co-founded a retinal disease gene therapy company Avalanche Biotechnologies (now Adverum Biotechnologies) where he serves as a member of the board of directors.


Education & Accomplishments
Mitch has been named inventor on 15 issued U.S. patents. He received his Ph.D. in Biochemistry and Molecular Biology from Harvard University and a B.S. in Biochemistry and Microbiology from the University of California at Berkeley. He completed a post-doctoral fellowship at the Whitehead Institute for Biomedical Research at the Massachusetts Institute of Technology.

Check out our open roles

Interested in working with people like Audra? We’re looking for pioneers and innovative thinkers committed to developing the next-generation of cell and gene therapies. Review our open roles and find your future.

apply now
“We will rapidly and efficiently advance each development program by providing our scientific founders with dedicated PD, manufacturing and drug development expertise and facilities. ”
Life @ElevateBio
Meet the talented people who make ElevateBio a great place to work.
meet the team